1Ravi B,Praveen A,Rohini H,et al. Ulcerative colitis associated with Takayasu arteritis. International Journal of Cardiology, 2003, (88): 91-93.
2Hiromi S,Akemi I,Hideki I,et al. Prevention of gut inflammation by Bifidobacterium in dextran sulfate-treated gnotobiotic mice associated with Bacteroides strainsisolated from ulcerative colitis patients. Microbes and Infection ,2003, (5) : 115-122.
3Alicja Wiercin'ska-Drapalo,Robert Flisiak,Danuta Prokopowicz. Effect of ulcerative colitis treatment on transforming growth factor h1 in plasma and rectal mucosa. Regulatory Peptides, 2003, (113): 57-61.
4Toyoda H, et al. Gastroenterology, 1993, 104(3): 741-748.
5Jesu' s K. Yamamoto-Furusho, Luis F. Uscanga,et al.Clinical and Genetic Heterogeneity in Mexican Patients With Ulcerative Colitis. Human Immunology, 2003,(64):119-123.
6Hideki Masuda MD,Yasuo Takahashi MD,Satoshi Asai MD. Distinct Gene Expression of Osteopontin in Patients with Ulcerative Colitis. Journal of Surgical Research,2003,(111) :85-90.
7Hiroaki N ,Nagamu I,Toshifumi H. Association between the interleukin-1 receptor antagonist polymorphism and ulcerative colitis with younger age at diagnosis.Immunology Letters, 2003,90 : 53-57.
8Ludmila N. Bubnova. I Irina E. HLA Ⅱ class polymorphism in patients with ulcerative colitis. Immunohematology.
9Juan Luis Fdez-Morera, Luis Rodrigo, Antonio Lo'pezVa'zquez. MHC Class Ⅰ Chain-Related Gene A Transmembrane Polymorphism Modulates the Extension of Ulcerative Colitis. Human Immunology, 2003, 64: 816-822.
